hClock gene expression in human colorectal carcinoma

Wang,Liying; Chen,Bozan; Wang,Yaping; Sun,Ning; Lu,Chao; Qian,Ruizhe; Hua,Luchun

doi:10.3892/mmr.2013.1643

hClock gene expression in human colorectal carcinoma

Authors:
- Liying Wang
- Bozan Chen
- Yaping Wang
- Ning Sun
- Chao Lu
- Ruizhe Qian
- Luchun Hua
View Affiliations

Affiliations: Clinical Skills Learning Center, School of Basic Medical Sciences, Fudan University, Shanghai 200032, P.R. China, Department of Surgery, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China, Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, P.R. China
Published online on: August 16, 2013 https://doi.org/10.3892/mmr.2013.1643
Pages: 1017-1022

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In this study, we aimed to investigate changes in the expression of human Clock (hClock), a gene at the core of the circadian gene family, in colorectal carcinomas (CRCs) and to discuss the possible effects. Previous studies have revealed that the disruption of circadian rhythms is one of the endogenous factors that contribute to the initiation and development of CRCs. However, the underlying molecular changes to the circadian genes associated with CRCs have not been explored. Immunofluorescence and quantitative polymerase chain reaction (qPCR) analysis of the hCLOCK protein and gene expression were performed in 30 cases of CRC. The hCLOCK protein was expressed in all specimens obtained from 30 CRC patients. Higher levels of hCLOCK expression were observed in human CRC tissues compared with the paired non-cancerous tissues. hCLOCK expression was significantly higher in poorly differentiated, or late-stage, Dukes' grade tumors and in 64.3% of tumor cases with lymph node metastasis. The hClock gene was expressed in all specimens. A significantly higher expression of hClock was found in human CRC cases compared with paired non-cancerous tissues. There was a strong positive linear correlation between hClock gene expression and protein expression in human CRCs. A strong positive linear correlation was also found between hClock gene expression and ARNT, HIF-1α and VEGF expression in human CRCs. There was no significant correlation between hClock and Bak, Bax, Bid, tumor necrosis factor receptor I (TNFR I) and TNFR II. The circadian gene hClock was stably expressed in human colorectal mucosa and was important in regulating the expression of downstream clock-controlled genes. hCLOCK may interact with HIF-1α/ARNT and activate VEGF to stimulate tumor angiogenesis and metastasis.

View Figures

View References

1	Panda S, Hogenesch JB and Kay SA: Circadian rhythms from flies to human. Nature. 417:329–335. 2002. View Article : Google Scholar : PubMed/NCBI
2	Chen-Goodspeed M and Lee CC: Tumor suppression and circadian function. J Biol Rhythms. 22:291–298. 2007. View Article : Google Scholar
3	Ko CH and Takahashi JS: Molecular components of the mammalian circadian clock. Hum Mol Genet. 15:R271–277. 2006. View Article : Google Scholar : PubMed/NCBI
4	Krugluger W, Brandstaetter A, Kállay E, et al: Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer Res. 67:7917–7922. 2007. View Article : Google Scholar
5	Wang Y, Hua L, Lu C and Chen Z: Expression of circadian clock gene human Period2 (hPer2) in human colorectal carcinoma. World J Surg Oncol. 9:1662011. View Article : Google Scholar : PubMed/NCBI
6	Hoffman AE, Yi CH, Zheng T, et al: CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer Res. 70:1459–1468. 2010. View Article : Google Scholar : PubMed/NCBI
7	Alhopuro P, Björklund M, Sammalkorpi H, et al: Mutations in the circadian gene CLOCK in colorectal cancer. Mol Cancer Res. 8:952–960. 2010. View Article : Google Scholar : PubMed/NCBI
8	Oshima T, Takenoshita S, Akaike M, et al: Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncology reports. 25:1439–1446. 2011. View Article : Google Scholar : PubMed/NCBI
9	Zheng S and Cai SR: Colorectal cancer epidemiology and prevention study in China. Chinese-German J Clin Oncol. 2:72–75. 2003. View Article : Google Scholar
10	Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
11	Zheng S and Cai SR: Colorectal cancer epidemiology and prevention study in China. Chinese-German J Clin Oncol. 2:72–75. 2003. View Article : Google Scholar
12	Zhang EE, Liu AC, Hirota T, et al: A genome-wide RNAi screen for modifiers of the circadian clock in human cells. Cell. 139:199–210. 2009. View Article : Google Scholar : PubMed/NCBI
13	Scheving LA: Biological clocks and the digestive system. Gastroenterology. 119:536–549. 2000. View Article : Google Scholar
14	Reppert SM and Weaver DR: Coordination of circadian timing in mammals. Nature. 418:935–41. 2002. View Article : Google Scholar : PubMed/NCBI
15	Hirota T and Fukada Y: Resetting mechanism of central and peripheral circadian clocks in mammals. Zoolog Sci. 21:359–68. 2004. View Article : Google Scholar : PubMed/NCBI
16	Innominato PF, Focan C, Gorlia T, et al: Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res. 69:4700–4707. 2009. View Article : Google Scholar : PubMed/NCBI
17	Block KI, Block PB, Fox SR, et al: Making circadian cancer therapy practical. Integr Cancer Ther. 8:371–386. 2009. View Article : Google Scholar : PubMed/NCBI
18	Gekakis N, Stakins D, Nguyen HB, et al: Role of the CLOCK protein in the mammalian circadian mechanism. Science. 280:1564–1569. 1998. View Article : Google Scholar : PubMed/NCBI
19	Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F and Okamura H: Control mechanism of the circadian clock for timing of cell division in vivo. Science. 302:255–259. 2003. View Article : Google Scholar : PubMed/NCBI
20	Fu L, Pelicano H, Liu J, Huang P and Lee C: The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 111:41–50. 2002. View Article : Google Scholar : PubMed/NCBI
21	Polidarová L, Soták M, Sládek M, Pacha J and Sumová A: Temporal gradient in the clock gene and cell-cycle checkpoint kinase Weel expression along the gut. Chronobiol Int. 26:607–620. 2009.PubMed/NCBI
22	Gery S and Koeffler HP: The role of circadian regulation in cancer. Cold Spring Harb Symp Quant Biol. 72:459–464. 2007. View Article : Google Scholar
23	Park JE, Lee DH, Lee JA, Park SG, Kim NS, Park BC and Cho S: Annexin A3 is a potential angiogenic mediator. Biochem Biophys Res Commun. 337:1283–1287. 2005. View Article : Google Scholar : PubMed/NCBI
24	Chau NM, Rogers P, Aherne W, et al: Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors. Cancer Res. 65:4918–4928. 2005. View Article : Google Scholar